ETBI OTC
Eastgate Biotech Corp.
1W: +0.0%
1M: -10.0%
3M: -10.0%
YTD: -10.0%
1Y: -10.0%
3Y: -49.1%
5Y: +170.0%
$0.00
-0.00 (-81.48%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$114K
+144.1% ▲
Capital Expenditures
$54K
+0.0% ▲
5Y CAGR: -11.7%
Free Cash Flow
$60K
+123.3% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$6K
+150.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$3M | -$4M | -$1M | -$4M |
| Depreciation & Amort. | $44K | $0 | $73K | $112K | $175K |
| Stock-Based Comp. | $1K | $833 | $0 | $0 | $0 |
| Change in Working Capital | $3M | $2M | $2M | $664K | $1M |
| Other Non-Cash Items | $1M | $1M | -$986K | $748K | $2M |
| Operating Cash Flow | -$568K | -$389K | -$1M | -$258K | $114K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$48K | $0 | -$54K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$48K | $0 | -$54K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$6K | $322K | $2M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $308K | $0 | $0 | $701K | $552K |
| Financing Cash Flow | $327K | $322K | $2M | $701K | $552K |
| Net Change in Cash | -$267K | -$19K | $151K | -$11K | $6K |
| Cash End of Period | $19K | $0 | $16K | $4K | $10K |
| Free Cash Flow | -$568K | -$389K | -$1M | -$258K | $60K |